Prenetics Global (PRE)
Sells IM8 nutrition products and CircleDNA consumer genetic testing worldwide.
Something off on this page? Send us feedback.
IM8 sells direct-to-consumer nutrition and longevity products, while CircleDNA provides consumer DNA testing. After divesting oncology, distribution, and cancer-detection holdings, the operating portfolio is concentrated on these two consumer-health brands.
IM8 is the flagship consumer-health brand, selling nutrition and longevity products directly to customers. It launched with Daily Ultimate Essentials and Daily Ultimate Longevity, and it began shipping across numerous countries and regions.
CircleDNA provides consumer DNA testing, carrying forward the company’s genetic-testing base alongside the newer supplement brand. The business has evolved from genetic testing and COVID-era diagnostics toward direct-to-consumer health and longevity.
Divestitures of ACT Genomics, Europa’s 3PL business, and the Insighta stake concentrated continuing operations on IM8 and CircleDNA. The company is Hong Kong-founded and Nasdaq-listed through a SPAC business combination, and the two-brand focus is its current operating structure.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 17, 2026 | Craig-Hallum | Initiate | Rating: —Target: — | Target: $40 |
| Aug 27, 2026 | B. Riley | Initiate | Rating: — | |
| Jul 15, 2026 | Lake Street | Reiterate | Rating: —Target: — | Target: $35 |
| Feb 11, 2026 | Roth Capital | Target | Target: — | Target: $36 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $109.4M · Total debt $682.0K · Total assets $153.7M · Shareholders' equity $93.0M
- Revenue
- $46.5M
- Operating income
- −$21.9M
- Net income
- −$9.0M
No dividends on record.
| Institutions | 7.16% | 1.22M shares | |
|---|---|---|---|
| 27 holders · as of Jun 30, 2026 | |||
| Insiders | 14.11% | 2.40M shares | |
| 7 holders · as of Sep 4, 2026 | |||
| Other | 78.73% | 13.38M shares | |
| remainder | |||
17.00M company shares as of Sep 15, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Danny Sheng Wu YeungInsiderdirector, officer: Chief Executive Officer | 9.96% | 112,416 · 1.58M | filed Aug 24, 2026 |
Hoi Chun LoInsiderofficer: Chief Financial Officer | 3.33% | 566,013 | filed Aug 24, 2026 |
Prospect Capital Advisors, LLCInstitution | 1.39% | 235,800 | as of Jun 30, 2026 |
Jane Street Group, LLCInstitution | 1.32% | 225,093 | as of Jun 30, 2026 |
Goldman Sachs Group IncInstitution | 0.99% | 168,733 | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 25, 2026 | Brian J. Rosin | officer: CFO of IM8 (US) LLC | +5,100 | $22.80 |
| Aug 24, 2026 | Brian J. Rosin | officer: CFO of IM8 (US) LLC | +18,000 | $21.19 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | director, officer: Chief Executive Officer | +17,181 | $21.23 |
| Aug 20, 2026 | Danny Sheng Wu Yeung | director, officer: Chief Executive Officer | +7,500 | $18.31 |
- Herbalife
Global personalized nutrition across wellness and sports formulas
- USANA Health Sciences
Worldwide nutritional supplements through a broad wellness network
- Nature's Sunshine Products
Herbal and nutritional supplements with expanding digital reach
CompareAfter hours
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Prenetics Global | $22.87 | −0.08% | $413.8M | — | — | 2.9 | +162.9% |
| Herbalife | $12.20 | −0.37% | $1.24B | 7.7 | 4.6 | 0.2 | +5.4% |
| USANA Health Sciences | $14.78 | +0.14% | $267.5M | — | 14.5 | 0.3 | −5.3% |
| Nature's Sunshine Products | $13.27 | +0.36% | $229.0M | 12.9 | 12.3 | 0.5 | +2.0% |
| Median | 10.3 | 12.3 | 0.3 | +2.0% |